Tight control of cell-cycle progression is critical for T-lymphocytes to function properly. Slfn1 (Schlafen1) has been reported to play an important role in the establishment and maintenance of quiescence in T-lymphocytes. However, how Slfn1 accomplishes this critical function remains poorly understood. In the present study, we show that nuclear localization is a prerequisite for Slfn1 to induce cell-cycle arrest, with DnaJB6, identified as a new Slfn1-binding protein, playing a pivotal role in this process. DnaJB6, a chaperone protein of the DnaJ/Hsp (heatshock protein) 40 family, stabilizes Slfn1 together with its partner Hsp70, and, more importantly, it enhances the nuclear import of Slfn1. Overexpression of DnaJB6 was found to increase Slfn1 nuclear accumulation and resulted in cell-cycle arrest, whereas, in DnaJB6 knock-down cells, Slfn1 was mainly sequestered in the cytoplasm and no cell-cycle arrest was observed. Furthermore, transgenic expression of DnaJB6 in T-lineage cells inhibited Slfn1's degradation, promoted its nuclear import and ultimately led to suppression of T-cell proliferation upon TCR (T-cell receptor) activation. In addition, DnaJB6 increased Slfn1's effect on its downstream target cyclin D1 in co-transfected cells.
INTRODUCTION
Mature T-cells circulate through the blood and peripheral lymphoid organs in a quiescent or resting state until they encounter their cognate antigens bound to MHC on the surface of antigenpresenting cells [1, 2] . Presumably, naïve T-cells maintain quiescence to save resources (energy and space) to enable a vast repertoire of T-cells to be maintained [3, 4] , of which only a small fraction will be clonally selected to proliferate upon antigen stimulation during the lifetime of the host. This quiescent state is essential for T-cell function and is actively controlled, rather than simply resulting from the absence of activation signals. Disruption of quiescence of T-cells triggers inappropriate immune responses and can lead to leukaemia, lymphoma and various autoimmune diseases [5] [6] [7] [8] . Given the indispensable role of the quiescent state in T-lymphocyte homoeostasis, it is of great interest to understand how the quiescent state is maintained and controlled. Previous work has identified several molecules that are involved in the maintenance of lymphocyte quiescence, including the transcription factors LKLF (lung Krüppel-like factor), Tob and Ikaros, and tumour suppressor PTEN (phosphatase and tensin homologue deleted on chromosome 10) [9] [10] [11] [12] . Recently, Hedrick and co-workers reported that Slfn1 (Schlafen1) plays a crucial role in establishing the quiescent state in lymphocytes [13] .
Slfn1 is a member of the Schlafen family defined by a conserved domain with unknown function [13] . Members of this family have been shown to regulate lymphocyte differentiation and cell-cycle progression. Slfn1 is specifically expressed in T-lineage cells, but not in B-cells, and is up-regulated approx. 100-fold during the differentiation from CD4 + CD8 + DP (double-positive) to CD4 + or CD8
+ SP (single-positive) thymocytes [13] . The mRNA of Slfn1 is highly expressed in quiescent SP thymocytes and T-cells, and the expression substantially decreases after TCR (T-cell receptor)-mediated activation [13] . The selective expression of Slfn1 in resting T-cells suggests that Slfn1 is required for maintaining the quiescent state. It has also been shown that Slfn1 induces cellcycle arrest of T-cells through inhibiting the expression of cyclin D1 [14] , although the pathways and proteins involved remain largely unknown.
Hsps (heat-shock proteins) are key components of cellular chaperones that prevent protein misfolding and aggregation in the crowded cellular environment [15, 16] . Hsp40 and Hsp70 are two important members of this family and often exert their function as partners. Hsp40s (also known as DnaJ proteins) are defined by the presence of an approx. 70-amino-acid region known as the J-domain, which is responsible for interacting with the ATPase domain, and possibly the substrate-binding domain of its partner Hsp70 [17] . On the basis of a survey of EST (expressed sequence tag) databases representing different mouse tissues and embryonic stages, more than 40 DnaJ/Hsp40-related genes are expressed in mammals [18] . Besides the general function as chaperones, many Hsp40 proteins possess specific functions such as cellcycle regulation, transcriptional activation, signal transduction and tumour suppression. Accumulating evidence suggests that Hsp40 family members play a role in both innate and adaptive immunity [19] [20] [21] [22] .
To address the molecular mechanism of Slfn1-mediated cellcycle arrest, we performed a yeast two-hybrid screen to isolate proteins interacting with Slfn1 using the conserved Slfn domain as bait. The chaperone protein DnaJB6, a member of the Hsp40 family previously named Mrj, was found to bind specifically to Slfn1. We showed that, in co-transfected cells, DnaJB6 increased Slfn1 protein levels and promoted its translocation to the nucleus, and thereby contributed to Slfn1-mediated cellcycle arrest. Knockdown of endogenous DnaJB6 by RNAi (RNA interference) led to the predominant cytoplasmic presence of Slfn1 and subsequently diminished its activity in cell-cycle arrest. Furthermore, transgenic expression of DnaJB6 in T-lineage cells prevented Slfn1's degradation, increased its nuclear localization and ultimately led to suppressed TCR-triggered T-cell proliferation. Finally, DnaJB6 enhanced Slfn1's inhibitory effect on cyclin D1 expression. Together, these results support the concept that DnaJB6 stabilizes Slfn1, moderates its localization and enhances its cell-cycle-arrest-promoting function.
MATERIALS AND METHODS

Mice
A cDNA encoding DnaJB6 was obtained by RT (reverse transcription)-PCR from thymocyte RNA preparations and then placed under the control of human CD2 promoter and locus control region in the transgenic expression vector p29 2 (from Dr Remy Bosselut, Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, U.S.A.). Transgenic mice were generated and maintained on the C57BL/6 background. Mice were genotyped by PCR of tail DNA. All animals were housed in a specific pathogenfree facility. Animal experimentation protocols were approved by the Shanghai Institutes for Biological Sciences Institutional Animal Care and Use Committee.
Antibodies
The following monoclonal antibodies were from BD Pharmingen: anti-TCR (H57-597), anti-CD4 (RM4.4 and GK1.5), anti-CD8 (53-6.7), anti-CD28 (37.51) and anti-cyclin D1. Anti-HA (haemagglutinin) was from Santa Cruz Biotechnology. Anti-FLAG was from Sigma. DNA fragments encoding amino acids 1-207 of mouse Slfn1 and amino acids 52-242 of mouse DnaJB6 were constructed separately into pGEX-4T-1 vector (GE Healthcare) to express GST (glutathione transferase) fusion proteins according to the manufacturer's protocols. The purified GST-fusion proteins were then used as antigens to immunize rabbits for generation of anti-Slfn1 and anti-DnaJB6 polyclonal antibodies using standard protocols.
Cells and plasmids
HEK-293T (human embryonic kidney) or NIH 3T3 mouse fibroblast cells were cultured in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % FBS (fetal bovine serum) at 37
• C under 5 % CO 2 . Cells were transfected by calcium phosphate or with Lipofectamine TM 2000 (Invitrogen) according to the manufacturer's instructions. cDNAs encoding Slfn1, DnaJB6 and Hsp70 were amplified by RT-PCR from total RNA isolated from mouse thymocyte and cloned into the HA-or FLAG-tagged eukaryotic expression vector pcDNA3.0. pGFP-Slfn1, pRFP-DnaJB6 and pRFP-Hsp70 were generated by subcloning the Slfn1, DnaJB6 and Hsp70 fragments into pEGFP-C1 and pERFP vectors respectively. pLAT and pβ-actin were generated by inserting the LAT (linker for activation of T-cells) or β-actin fragments into vector pcDNA3.0. pLAT-GFP-Slfn1, pβ-actin-GFP-Slfn1, pLAT-RFP-DnaJB6 and pβ-actin-RFP-DnaJB6 were generated by inserting the GFP (green fluorescent protein)-Slfn1, RFP (red fluorescent protein)-DnaJB6 fragments into the pLAT and pβ-actin vectors respectively. The human cyclin D1 promoter-reporter vector (−1745D1-Luc) was a gift from Dr Richard Pestell (Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, U.S.A.).
Yeast two-hybrid screening
The DNA fragment encoding amino acids 208-337 of Slfn1, representing the conserved domain of the Slfn family, was cloned into the bait vector pGBKT7 with GAL4 DNA-binding domain. The bait plasmid pGBKT7-Slfnco was transformed into the yeast strain AH109, which was transformed with a mouse lymphoma cDNA library in pACT vector (Clontech), and cells were selected on yeast synthetic medium lacking histidine, leucine, tryptophan and adenine. Colonies surviving after 4-6 days at 30
• C were tested for β-galactosidase activity, and plasmid cDNAs were prepared from positive colonies and sequenced for identification of cDNA clones.
Immunoprecipitation and immunoblot analysis
Cells were lysed on ice for 30 min in lysis buffer (0.5 % Triton X-100, 50 mM Tris/HCl, pH 7.4, 150 mM NaCl and 1 mM EDTA) with protease inhibitor cocktail. The cell lysates were clarified by centrifugation at 12 000 g for 10 min, incubated with antiSlfn1 antibody or rabbit IgG and then with Protein A/G-agarose beads. After washing, 2× sample loading buffer was added to the immunoprecipitates. Samples were subjected to immunoblot analysis with anti-DnaJB6 antibody and HRP (horseradish peroxidase)-conjugated secondary antibody (Santa Cruz Biotechnology).
PI (propidium iodide) staining and FACS analysis
A total of 10 7 cells were trypsinized, fixed with 70 % ethanol at 4
• C for at least 2 h. After fixation, the cells were centrifuged at 3500 g for 10 min, washed with PBS, and resuspended in 300 μl of PBS containing 200 μg/ml RNase (Sigma) and 5 μg/ml PI (Sigma). Samples were incubated for 40 min at 37
• C and analysed using a FACSCalibur TM instrument (Becton Dickinson). Cellcycle analysis was performed using FlowJo software (Treestar).
Confocal laser-scanning immunofluorescence microscopy
HEK-293T or NIH 3T3 cells were transfected with plasmids as indicated to analyse the subcellular localization of Slfn1. Cells growing on coverslips were fixed with 4 % (w/v) paraformaldehyde for 15 min. The nuclei were stained with DAPI (4 ,6-diamidino-2-phenylindole) (Sigma). To analyse the subcellular localization of Slfn1 in T-cells, T-cells were fixed with 4 % (w/v) paraformaldehyde in PBS before deposition on poly-L-lysinecoated slides and washing three times for 20 min after adherance, then incubated with anti-Slfn1 antibody at 4
• C for 16 h. After washing, the cells were labelled with FITC-conjugated goat anti-rabbit IgG [H+L (heavy and light chains)] (1:500 dilution; Chemicon) for 30 min, then incubated with DAPI (0.5 μg/ml) for 5 min. Slides were mounted with Poly-Mount (Polysciences) after washing. Images were acquired with a TCS SP2 confocal microscope.
T-cell preparation, purification and stimulation
Single-cell thymocyte and lymphocyte suspensions were prepared and stained for detecting the expression of cell-surface markers as described in [23] . DP, CD4
+ SP thymocytes and CD4 T-cells were purified as described [24] by cell sorting on a FACSAria TM (BDBiosciences). Cell purity, assessed by surface staining and flow cytometry, was more than 90 %. Cells were cultured in complete medium (RPMI 1640 supplemented with 10 % FBS, glutamine and 2-mercaptoethanol). IM (ionomycin, 0.2 μg/ml) and PMA (10 ng/ml) were used to stimulate T-cells.
T-cell proliferation assay
Lymphocytes (2 × 10 6 cells/ml) were labelled with 5 μM CFSE (carboxyfluorescein diacetate succinimidyl ester) in labelling buffer [HBSS (Hanks balanced salt solution) supplemented with 2 % FCS] for 10 min at 37
• C in the dark, with occasional stirring. Labelling was stopped by 10-fold dilution with labelling buffer. Cells were centrifuged at 490 g for 5 min and resuspended at 10 6 cells/ml in complete medium. Labelled cells were incubated at 37
• C for 48 h in plates previously coated with anti-TCR (10 μg/ml) either alone or together with anti-CD28 (10 μg/ml). For analysis, cells were washed twice with staining buffer (HBSS containing 0.1 % BSA and 0.1 % sodium azide), stained with APC (allophycocyanin)-conjugated anti-CD8 or anti-CD4 antibodies and analysed by flow cytometry. Live cells were identified by forward light scatter and PI gating.
RNAi
The RNAi experiment was performed using the pSUPER system (Oligoengine). To construct DnaJB6 RNAi plasmid, two 64-mer oligonucleotides, 5 -GATCCCCATAGAAGCCGAGG-TGCGGCTTCAAGAGAGCCGCACCTCGGCTTCTATTTTT-TGGAAA-3 and 5 -AGCTTTTCCAAAAAATAGAAGCCGAG-GTGCGGCTCTCTTGAAGCCGCACCTCGGCTTCTATGGG-3 , were synthesized and annealed to produce a double-stranded DNA linker; the DNA linker was then inserted into vector pSUPER. Correct insertion was verified by DNA sequencing. Stable cell lines were generated by transfecting NIH 3T3 cells with pSUPERDnaJB6i plasmid or empty pSUPER (control) and selected with 400 μg/ml G418 (AG Scientific). Two different DnaJB6 knockdown clones were used in the experiments.
Luciferase reporter assay
NIH 3T3 cells were cultured in six-well plates and transfected with 2 μg of DNA using 4 μl of Lipofectamine TM 2000 reagent (Invitrogen). In all experiments, cells were transfected with 60 ng of Renilla luciferase, 440 ng of pGL3-cyclin D1 and 500 ng of pcDNA3.0-Slfn1 or 500 ng of pcDNA3.0-DnaJB6, or both. The total amount of DNA for each transfection was adjusted to 2 μg/well by adding empty vectors. Cell extracts were prepared 48 h after transfection, and luciferase activities were measured using the Promega dual-luciferase assay system. The luciferase activity of each construct was calculated relative to that of control vector pGL3-Basic. All experiments were repeated in triplicate.
RESULTS
Slfn1 is located in both the cytoplasm and the nucleus of quiescent T-cells
Slfn1 mRNA has been found to be preferentially expressed in T-cells and significantly up-regulated as a result of thymocyte + SP (CD4SP) thymocytes and CD4 T-cells were fixed with 4 % (w/v) paraformaldehyde and incubated with anti-Slfn1 antibody (1:1000), the cells were then labelled with FITC-conjugated goat anti-rabbit IgG (H+L) (1:500). Images were acquired using a TCS SP2 confocal microscope.
positive selection [13] . Immunoblot analysis with Slfn1 rabbit antiserum showed a similar expression pattern of Slfn1 protein in purified populations of T-lineage cells ( Figure 1A ). Slfn1 protein was highly expressed in CD4
+ SP thymocytes and CD4 T-cells, but barely detectable in less mature DP thymocytes. Immunofluorescence staining showed that endogenous Slfn1 was distributed throughout the whole CD4
+ SP thymocytes and CD4 T-cells with a preferentially cytoplasmic localization ( Figure 1B ).
Slfn1 inhibits cell growth in a nuclear localizationdependent manner
Slfn1 has been shown to impede thymocytes development and cause a G 1 arrest in fibroblasts [13] . Accordingly, we chose NIH 3T3 cells to analyse further the subcellular localization of Slfn1 with HEK-293T cells used as a control. Slfn1 was shown by immunoblotting to be expressed at a much lower level in NIH 3T3 cells than in T-cells, whereas it was not detectable in HEK-293T cells (Figure 2A ). After verifying that overexpression of GFP alone had no effect on cell cycle and tagging with GFP did not affect the function of Slfn1 (see Supplementary Figure S1 at http://www.BiochemJ.org/bj/413/bj4130239add.htm), we overexpressed GFP-tagged Slfn1 in NIH 3T3 and HEK-293T cells. To our surprise, the localization of Slfn1 in these two cell lines was strikingly different. Slfn1 was localized to both the cytoplasm and the nucleus in NIH 3T3 cells, with a slight preference for the nucleus, whereas, in HEK-293T cells, it was primarily found in the cytoplasm ( Figure 2B ).
We then tested whether the subcellular distribution of Slfn1 affects its activity. We sorted the GFP-negative (non transfected) and GFP-positive (Slfn1-overexpressing) cells using FACS, then analysed the cell cycle by PI staining. We found that Slfn1-overexpressing (GFP-positive) NIH 3T3 cells exhibited more than 2-fold reduction of S-and G 2 /M-phase populations (27.8 to 12 %) compared with non-transfected (GFP-negative) cells in the same dish ( Figure 2C ). However, no difference was found in HEK-293T cells where Slfn1 was mostly cytoplasmic. These results indicate that Slfn1 blocks cell-cycle progression in NIH 3T3 cells, but not in HEK-293T cells. Similar results were obtained in our colonyformation assay (Supplementary Figure S1) , where Slfn1 blocked colony formation in NIH 3T3 cells, but not in HEK-293T cells. These observations suggest that Slfn1-mediated cell-cycle arrest may rely on its nuclear localization.
To test whether Slfn1's effect on the cell cycle requires its nuclear localization, we fused GFP-Slfn1 with LAT or β-actin ( Figure 2D ) to retain Slfn1 in the cytoplasm. LAT is a transmembrane protein that localizes to lipid rafts [25] , and β-actin is a housekeeping protein that mainly stays in the cytoplasm [26] . As shown in Figure 2 (E) (left-hand panels), both LAT-GFPSlfn1 and β-actin-GFP-Slfn1 were efficiently retained in the cytoplasm of NIH 3T3 cells, although a trace of β-actin-GFPSlfn1 was detected in the nucleus. No significant change in cellcycle distribution was observed in either LAT-GFP-Slfn1 or β-actin-GFP-Slfn1 expressing NIH 3T3 cells when compared with non-transfected NIH 3T3 cells in the same dish ( Figure 2E , right-hand panels). These results demonstrate that nuclear Slfn1 is required for Slfn1-mediated cell-cycle arrest.
DnaJB6 is identified as a Slfn1-interacting protein
Analysis of the Slfn1 protein sequence revealed the lack of a typical nuclear localization signal. We hypothesized that Slfn1 is transported into the nucleus by a specific cellular binding partner. To search for Slfn1-binding proteins, we performed a yeast twohybrid screen using the conserved domain of Slfn (residues 208-337 of Slfn1, Figure 3A ) as bait. A total of 25 positive clones were isolated from a mouse lymphoma cDNA library and sequencing revealed six clones that encoded an open reading frame of DnaJB6. DnaJB6 belongs to the DnaJ/Hsp40 family of cochaperone proteins that was previously reported to be expressed ubiquitously [27] . The Slfn1-DnaJB6 interaction was retested by the yeast two-hybrid assay. Only yeast co-transformed with Gal4AD (GAL4 activation domain)-DnaJB6 and Gal4BD (GAL4 DNA-binding domain)-Slfn1 constructs were able to grow in the high-stringency selective medium (see Supplementary Figure S2 at http://www.BiochemJ.org/bj/413/bj4130239add.htm).
Co-immunoprecipitation was used to verify the binding of DnaJB6 to Slfn1 in mammalian cells. As shown in Figure 3 (B) (left-hand panel), HA-DnaJB6 was co-immunoprecipitated with FLAG-Slfn1. We confirmed further that endogenous DnaJB6 was associated with Slfn1 in T-cells. DnaJB6 was specifically coimmunoprecipitated with anti-Slfn1 antibody from T-cell lysates, but not with control rabbit IgG ( Figure 3B, left-hand panel) . These results suggest that the interaction between DnaJB6 and Slfn1 is highly specific.
The DnaJ domain of DnaJB6 serves to bind the DnaK domain of chaperone Hsp70 [28] . To map the Slfnl-binding domain of DnaJB6, we made a series of HA-tagged C-terminal mutants of DnaJB6 and tested their affinity with Slfn1 in a co-immunoprecipitation assay ( Figure 3C, upper panel) . As shown in Figure 3(C) (lower panel), DnaJB6M4 (residues 1-146), DnaJB6M5 (residues 1-173) and DnaJB6M6 (residues 1-200) bound to Slfn1 with the same affinity as the wild-type protein, whereas DnaJB6M1 (residues 1-69), DnaJB6M2 (residues 1-99) and DnaJB6M3 (residues 1-131) failed to bind. These data indicate that the minimal Slfn1-interacting domain of DnaJB6 lies between residues 131 and 146.
DnaJB6 promotes nuclear translocation of Slfn1 and enhances Slfn1-mediated cell-cycle arrest
DnaJB6 is the only protein found in our yeast two-hybrid screen that is present in both the cytoplasm and the nucleus, whereas all other proteins are localized exclusively to the nucleus ( Figure 4A and Z. Yang and X. Liu, unpublished work). DnaJB6 is likely to be responsible for the nuclear import of Slfn1. Immunoblot analysis showed that the DnaJB6 level was significantly higher in NIH 3T3 cells than in HEK-293T cells ( Figure 4B ), which is consistent with the different subcellular distribution of Slfn1 in two cell lines. We next asked whether overexpressing DnaJB6 is able to relocate Slfn1 to the nucleus of HEK-293T cells. GFP-Slfn1 and RFP-DnaJB6 were co-expressed in HEK-293T cells to examine the intracelluar localization of Slfn1. As shown in Figure 4 (C), GFP-Slfn1 was translocated into the nucleus when co-transfected with RFP-DnaJB6, whereas GFP-Slfn1 alone was mostly localized in the cytoplasm. No change in the subcellular distribution of GFP-Slfn1 was observed when GFP-Slfn1 was co-expressed with RFP. These results demonstrate that overexpression of DnaJB6 in HEK-293T cells leads to nuclear import of Slfn1.
To test whether the enhanced nuclear localization of Slfn1 by DnaJB6 has an effect on Slfn1-mediated cell-cycle arrest, NIH 3T3 cells were co-transfected with different combinations of constructs and subjected to cell-cycle analysis. As shown in Figure 4 (D), the S-and G 2 /M-phase populations in co-transfected cells (11.6 %) were significantly reduced when compared with cells transfected with Slfn1 alone (17.9 %). Cells overexpressing DnaJB6 alone also exhibited a decrease in Sand G 2 /M-phase populations, presumably due to enhancement of endogenous Slfn1-mediated cell-cycle arrest in NIH 3T3 cells. Co-expression of DnaJB6 and Slfn1 in HEK-293T cells had no effect on cell-cycle progression, so we reason that HEK-293T cells lack other factors required for Slfn1 activity on cell cycle. Indeed, some binding partners of Slfn1 identified in the screen are not expressed in HEK-293T cells (Z. Yang and X. Liu, unpublished work).
Nuclear import of DnaJB6 is required for Slfn1's entry into the nucleus
The results above show that DnaJB6 facilitates nuclear import of Slfn1. To test whether DnaJB6 is required for the translocation, we employed RNAi to deplete endogenous DnaJB6 and investigated its effect on the subcellular localization and function of Slfn1 in NIH 3T3 cells. Four pairs of oligonucleotides were designed, with only one showing significant knockdown of endogenous DnaJB6 expression (results not shown). Two stable clones (RNAi-1 and RNAi-2), with moderate and near complete knockdown of DnaJB6 respectively ( Figure 5A ), were generated, and the intracellular localization of Slfn1 was examined. As shown in Figure 5 (B), more than 90 % of intact cells had preferential nuclear Slfn1 and it was reduced to 20 % or less when DnaJB6 was knocked down by RNAi. The more efficient RNAi-2 clone displayed a stronger inhibitory effect on nuclear localization of Slfn1 than RNAi-1. DnaJB6 knockdown also nearly abolished Slfn1-mediated cell-cycle arrest. Slfn1-overexpressing cells in S-and G 2 /M-phase ( Figure 5C ) increased from 11.2 % of the total cell population to 20.4 % in the RNAi-1 group and 27.9 % in the RNAi-2 group. We next asked whether nuclear localization of DnaJB6 is required for Slfn1's nuclear entry. We retained DnaJB6 in the cytoplasm of HEK-293T cells with a LAT or β-actin tag ( Figure 6A ) and subsequently evaluated Slfn1's nuclear translocation. Interestingly, we found that nuclear localization of GFP-Slfn1 was only observed in cells co-expressing RFP-DnaJB6, but not LAT-RFP-DnaJB6 and β-actin-RFP-DnaJB6 ( Figure 6B ). These data indicate that the nuclear localization of DnaJB6 is required for the translocation of Slfn1 into the nucleus. Further FACS analysis on NIH 3T3 cells showed that cytoplasmic retention of DnaJB6 had no effect on cell-cycle progression, presumably because endogenous Slfn1 could not redistribute to the nucleus ( Figure 6C) .
Members of the Hsp40 family typically work in combination with their respective Hsp70 partners [29, 30] . To examine whether Hsp70 is also involved in DnaJB6-mediated nuclear translocation of Slfn1, we first investigated whether Hsp70 is present in the DnaJB6-Slfn1 complex. We found that Hsp70 can co-immunoprecipitate with Slfn1 only in the presence, but not in the absence, of DnaJB6 (see Supplementary Figure S3A at http://www. BiochemJ.org/bj/413/bj4130239add.htm), suggesting that Hsp70 binds to Slfn1 through DnaJB6. We next overexpressed Hsp70 in HEK-293T cells and found that Hsp70 had no effect on the intracellular localization of Slfn1 (see Supplementary Figure 3B ). We also compared the effect of Hsp70 on cell-cycle progression with DnaJB6 in NIH 3T3 cells and found that, in contrast with DnaJB6, which induced roughly 2-fold decreases in the S+G 2 /Mphase population, overexpressing Hsp70 had no effect on the cell cycle (see Supplementary Figure S3C ). These results suggest that, unlike DnaJB6, Hsp70 alone is not sufficient to relocalize Slfn1 from the cytoplasm to the nucleus and inhibit cell-cycle progression.
DnaJB6 transgenic mice exhibit impaired T-cell proliferation
We subsequently investigated whether DnaJB6 participates in maintaining mature T-lymphocytes in a quiescent state. Expression of endogenous DnaJB6 was analysed in DP, CD4
+ SP thymocytes and CD4 T-cells, and similar expression levels were detected in all cells at three developmental stages ( Figure 7A ). Low expression levels of DnaJB6 in T-lineage cells prompted us to generate transgenic mice that overexpress DnaJB6 especially in T-lineage cells using DnaJB6 cDNA under the transcriptional control of the T-lineage-cell-specific human CD2 promoter ( Figure 4B ). Immunoblot analysis showed that the expression of DnaJB6 in thymocytes and T-cells increased approx. 6.9-and 5.1-fold respectively in transgenic animals compared with controls ( Figure 7B ). Transgenic mice had marginal changes in thymic cellularity and subset populations compared with those of control mice (results not shown), suggesting that DnaJB6 has no impact on the development of DP thymocyte in which Slfn1 expression is low.
To examine the effect of transgenic DnaJB6 on T-cell proliferation, CFSE-labelled T-cells were stimulated with plate-bound antibodies against the TCR with or without anti-CD28, as indicated. Since each daughter cell inherits approximately half of the CFSE label, CFSE fluorescence was analysed by flow cytometry to monitor cell division. As shown in Figure 7 (C), CD4 and CD8 T-cells from C57BL/6 or littermates underwent several rounds of division as is evident from the decreasing CFSE peaks. Strikingly, DnaJB6 transgenic CD8 T-cells mostly remained undivided. Of note, the division profile showed minor change in CD4 T-cells. These results indicate that transgenic DnaJB6 suppresses T-cell proliferation.
To verify that DnaJB6 impairs T-cell proliferation through Slfn1, we first carried out a Western blot to detect Slfn1 protein in T-cells from DnaJB6 transgenic mice and their non-transgenic littermate controls. Intriguingly, a higher level of Slfn1 protein was detected in DnaJB6 transgenic mouse T-cells ( Figure 7D) . Furthermore, unlike the T-cells from control mice, DnaJB6 transgenic T-cells exhibited less degradation of Slfn1 when stimulated with anti-TCR plus anti-CD28 antibodies. Secondly, immunofluorescence staining revealed that more Slfn1 was retained in the nucleus of DnaJB6 transgenic T-cells, but not of littermate T-cells ( Figure 7E ). We concluded from these observations that DnaJB6 stabilizes Slfn1 and translocates Slfn1 into the nucleus, and thus promotes cell-cycle arrest of T-cells.
Nuclear Slfn1 inhibits cyclin D1 expression
Cyclin D1 plays a key role in controlling S-phase entry by multiple mitogenic stimuli [31] . It was reported that Slfn1 causes cell-cycle arrest via down-regulating cyclin D1 expression using a luciferase assay [14] . Consistent with this observation, our immunoblot analysis showed that down-regulation of Slfn1 protein preceded up-regulation of cyclin D1 when T-cells were stimulated with PMA and IM. Importantly, this correlation was observed further when the stimulation was removed, where fluorescence analysis. Nuclear localization of GFP-Slfn1 was observed only in HEK-293T cells co-expressing RFP-DnaJB6 (which itself could distribute in the nucleus), but not LAT-RFP-DnaJB6 or β-actin-RFP-DnaJB6 (which were retained in the cytoplasm). (C) NIH 3T3 cells were transfected with the plasmids indicated and then used for flow cytometric analysis of DNA content. Compared with GFP-DnaJB6, LAT-GFP-DnaJB6 and β-actin-GFP-DnaJB6 had no effect on cell growth. Values given are proportions (%) of the cells analysed. up-regulation of Slfn1 protein was followed by down-regulation of cyclin D1 ( Figure 8A ). These results indicate that cyclin D1 is a downstream target of Slfn1. We then examined whether cyclin D1's expression can be affected by DnaJB6. As can be seen in Figure 8 (B), a stronger inhibition of cyclin D1 promoter activity was found in cells co-transfected with Slfn1 and DnaJB6 plasmids when compared with cells transfected with Slfn1 or DnaJB6 plasmids alone. This result indicates that DnaJB6 enhances Slfn1's inhibitory effect on cyclin D1 expression.
DISCUSSION
Spatial and temporal regulation of Slfn1 is critical for cell-cycle control of T-cells
Naïve T-lymphocytes enter a 'resting' state in which they are proliferatively quiescent and relatively resistant to apoptosis. The evolution of this state may reflect the necessity to maintain a large pool of quiescent peripheral T-cell clones while preventing spontaneous T-cell activation and the concomitant risk of cancer and autoimmune disease [32] . Slfn1's role appears to be to keep T-cells in such a 'resting' state by controlling cell-cycle entry. Dysregulated Slfn1 has been shown to have direct links with the early embryonic lethal DDK syndrome and systemic autoimmune diseases such as rheumatoid arthritis [33, 34] . Consistent with this requirement, we observed that Slfn1 is expressed in proliferationcompetent SP thymocytes and T-cells, but not the immature DP thymocytes.
The quiescent state must be disrupted rapidly when Tcells encounter their cognate antigen and re-established when pathogenic antigen is cleared. Cyclin D1 plays a central role in these processes through promoting entry into the cell cycle [35] . Aberrant up-regulation of cyclin D1 by chromosomal translocation is often associated with T-cell lymphomas [36] . In the present study, we have shown that Slfn1, temporally regulated by TCR signalling, effectively controls T-cell proliferation through inhibiting cyclin D1 expression. As shown in Figure 8 (A), Slfn1 was degraded rapidly in response to stimulation and reaccumulated upon removal of the stimulus, which switched the expression of cyclin D1 on and off to regulate the cell cycle. Additionally, we observed that Slfn1's mRNA level was down-regulated upon stimulation in T-cells (Y. Cao and X. Liu, unpublished work), suggesting that Slfn1 is actively regulated at both protein and mRNA levels. To date, however, how Slfn1 is regulated at transcriptional, translational and post-translational level is still largely unknown.
We also documented that spatial distribution of Slfn1 is critical for its function. Structural analysis suggests that Slfn1 belongs to a transcriptional regulator family containing an HTH (helix-turn-helix) domain. Except for DnaJB6, the Slfn1-binding proteins isolated from our screen are localized exclusively in the nucleus. Slfn1 probably exerts its function mainly in the nucleus. Consistent with this, we found that cell growth was not affected when Slfn1 was anchored to the plasma membrane or retained in the cytoplasm in NIH 3T3 cells, whereas cell-cycle arrest was enhanced when Slfn1 accumulated in the nucleus in the presence of DnaJB6. Thus the nuclear localization of Slfn1 is critical for the inhibition of cell growth. Considering that Slfn1 regulates the expression of cyclin D1, it would be interesting to examine whether it binds directly to the promoter of cyclin D1 as a transcriptional factor.
DnaJB6 regulates the stability of Slfn1
As a chaperone protein, DnaJB6 inhibits polyglutamine-dependent protein aggregation [37] , regulates keratin 8/18 organization [38] and mediates transcriptional repression through HDAC (histone deacetylase) recruitment [39] . It has been reported that mouse homozygous DnaJB6 mutants are lethal at mid-gestation, suggesting that DnaJB6 is essential for mouse embryogenesis [40] .
We identified DnaJB6 as a new Slfn1 regulatory protein in a yeast two-hybrid screen and confirmed the interaction both in vitro and in vivo. Slfn1 is a protein of 337 amino acids, of which 55 amino acids are glutamine and glutamic acid residues, making it very difficult to fold properly. In the present study, we have shown that DnaJB6 stabilizes Slfn1 and prevents its degradation. Immunofluorescence staining showed that the green fluorescence intensity was greater when DnaJB6-RFP and Slfn1-GFP were co-expressed in cells than that in cells expressing Slfn1-GFP alone. Importantly, a higher level of Slfn1 protein was detected in T-cells of DnaJB6 transgenic mice than in those of littermate controls. In addition, when T-cells were stimulated with anti-TCR plus anti-CD28 antibodies, less degradation of Slfn1 was observed in DnaJB6 transgenic T-cells. Together, these results indicate that DnaJB6 served as a stabilizing chaperone protein for Slfn1.
The stabilizing ability of DnaJB6 is important for Slfn1 to function properly. On the one hand, intrinsic instability of Slfn1 is required to facilitate a rapid degradation upon T-cells activation. Since Slfn1 has to be maintained at a relatively high level in resting T-cells, DnaJB6 function is critical.
DnaJB6 has a unique function to enhance nuclear import of Slfn1
In addition to stabilizing Slfn1, we found that DnaJB6 promotes the nuclear import of Slfn1. Most DnaJ domain-containing proteins localize exclusively in the cytoplasm [18] . DnaJB6, however, is found in both the cytoplasm and the nucleus. This unique distribution pattern implies a translocation-related function of DnaJB6 that is separated from its general foldingassisting ability. In the case of Slfn1, which lacks a typical nuclear localization signal, DnaJB6 is required for its translocation into the nucleus. In NIH 3T3 cells, down-regulation of DnaJB6 reduced nuclear import of Slfn1, whereas, in DnaJB6 transgenic T-cells, a high level of Slfn1 accumulation was detected in the nucleus. These results strongly indicate that DnaJB6 is necessary for Slfn1 to enter the nucleus, where it turns off gene expression to induce cell-cycle arrest.
Furthermore, our results show that the nuclear import of Slfn1 not only requires the presence of DnaJB6, but also the simultaneous nuclear localization of DnaJB6. Nuclear distribution of Slfn1 was barely detected when DnaJB6 was anchored to the membrane or retained in the cytoplasm. This finding also suggests that enhanced nuclear import of Slfn1 is not simply due to the increased protein level because of DnaJB6's stabilization. The precise mechanism of DnaJB6-promoted nuclear import of Slfn1 remains to be investigated. Considering the concurrent translocation of DnaJB6 and Slfn1, one possibility would be that DnaJB6, as a chaperone, binds to Slfn1 and forms a compact complex that is able to transport through the nuclear pores. It is also possible that Slfn1 is 'piggybacked' on to DnaJB6 to trigger the signal or force of nuclear import. Both hypotheses are currently under investigation in our laboratory.
Recently, several DnaJ domain-containing proteins have also been shown to regulate cell growth by modulating the localization of its associated proteins. For example, hTid-1 (DnaJA3), can induce cell-growth arrest through retaining IκBα (inhibitor of nuclear factor κBα) in the cytoplasm [41] . HLJ1 (DnaJB4) mobilizes STAT1 (signal transducer and activator of transcription 1) and p21 to down-regulate cyclin D1 and inhibit cell proliferation [42] . Our results provide another example that DnaJB6 induces cell-cycle arrest by assisting Slfn1's translocation into the nucleus. In NIH 3T3 cells, overexpression of DnaJB6 resulted in cell-cycle arrest, and, more convincingly, DnaJB6 transgenic mice showed a substantial defect in T-cell proliferation when compared with littermate control mice.
In conclusion, although its expression is controlled by TCR signalling, Slfn1 is actively regulated by DnaJB6 at the posttranslational level. DnaJB6 not only stabilizes Slfn1, but also promotes Slfn1's import to the nucleus where it inhibits cellcycle progression to establish and maintain the quiescent state of T-cells.
